<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00431899</url>
  </required_header>
  <id_info>
    <org_study_id>HDW3</org_study_id>
    <nct_id>NCT00431899</nct_id>
  </id_info>
  <brief_title>Effects of Omega 3 in Hemodialysis Patients</brief_title>
  <official_title>Effets of Fish Oil on Metabolic Fate of an Oral Glucose Load in Patients With End Stage Renal Disease Undergoing Hemodialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoire Régional de Nutrition Humaine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoire Régional de Nutrition Humaine</source>
  <brief_summary>
    <textblock>
      The aim of the study was to determine the effects of a 3-week fish oil oral supplementation
      on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2003</start_date>
  <completion_date>November 2003</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>plasma glucose utilization</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>glucose-induced thermogenesis</measure>
  </primary_outcome>
  <enrollment>8</enrollment>
  <condition>Hemodialysis</condition>
  <condition>End Stage Renal Disease</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>fish oil supplementation</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hemodialysis at least 6 months duration end stage renal disease

        Exclusion Criteria:

          -  - Age &lt; 18 y ou &gt; 75 y

          -  Hemodialysis &lt; 6 months

          -  Diabetes, obesity

          -  allergy to fish

          -  Asthma

          -  glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin

          -  erythropoïetin &lt; 3 months

          -  Cancer

          -  Hemoglobin &lt; 11 g/l

          -  disease &lt; 1 month

          -  pregnancy

          -  respiratory insufficiency

          -  intensive sport practice

          -  refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacques Delarue, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Cavale Blanche F-29200 Brest</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laboratoire Régional de Nutrition Humaine</name>
      <address>
        <city>Brest</city>
        <zip>F-29200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2007</study_first_submitted>
  <study_first_submitted_qc>February 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2007</study_first_posted>
  <last_update_submitted>March 2, 2016</last_update_submitted>
  <last_update_submitted_qc>March 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2016</last_update_posted>
  <keyword>nutrition</keyword>
  <keyword>omega 3 fatty acids</keyword>
  <keyword>insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

